BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38552292)

  • 1. Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling.
    Chen YJ; Li HF; Zhao FR; Yu M; Pan SY; Sun WZ; Yin YY; Zhu TT
    Int Immunopharmacol; 2024 May; 132():111946. PubMed ID: 38552292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
    Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
    Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of cordycepin in the treatment of pulmonary arterial hypertension in rats based on metabonomics and transcriptomics.
    Lin J; Chen R; Liao H; Zhang Y; Zheng Z; Hong C
    Sci Rep; 2024 May; 14(1):12431. PubMed ID: 38816406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamine regulatory processes and oxidative stress in monocrotaline-treated pulmonary artery endothelial cells.
    Aziz SM; Toborek M; Hennig B; Endean E; Lipke DW
    Cell Biol Int; 1997 Dec; 21(12):801-12. PubMed ID: 9812344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
    Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
    Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
    Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
    Tang C; Luo Y; Li S; Huang B; Xu S; Li L
    Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
    Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
    Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
    BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.
    Li F; Wang D; Wang H; Chen L; Sun X; Wan Y
    Respir Res; 2021 Aug; 22(1):239. PubMed ID: 34465322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
    Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
    BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel alleviates monocrotaline-induced pulmonary arterial hypertension via inhibition of FoxO1-mediated autophagy.
    Feng W; Wang J; Yan X; Zhai C; Shi W; Wang Q; Zhang Q; Li M
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):605-613. PubMed ID: 30683943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension.
    Gomez-Puerto MC; Sun XQ; Schalij I; Orriols M; Pan X; Szulcek R; Goumans MJ; Bogaard HJ; Zhou Q; Ten Dijke P
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesyl diphosphate synthase regulated endothelial proliferation and autophagy during rat pulmonary arterial hypertension induced by monocrotaline.
    Jin T; Lu J; Lv Q; Gong Y; Feng Z; Ying H; Wang M; Fu G; Jiang D
    Mol Med; 2022 Aug; 28(1):94. PubMed ID: 35962329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Li Q; Wang J; Zhu X; Zeng Z; Wu X; Xu Y; Xie J; Yu J
    Biomed Pharmacother; 2017 Dec; 96():825-833. PubMed ID: 29078260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
    Gao H; Cheng Y; Zong L; Huang L; Qiao C; Li W; Gong B; Hu J; Liu H; Wang X; Zhao C
    Clin Exp Hypertens; 2017; 39(1):34-41. PubMed ID: 28055284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.